Asako Mori1, Hirotaka Nishi2, Toru Sasaki1, Yuzo Nagamitsu1, Rie Kawaguchi3, Aikou Okamoto3, Masahiko Kuroda4, Keiichi Isaka1. 1. Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan. 2. Department of Obstetrics and Gynecology, Tokyo Medical University, Tokyo, Japan. Electronic address: nishih@tokyo-med.ac.jp. 3. Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan. 4. Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan.
Abstract
INTRODUCTION: Hypoxia occurs in the first trimester of placental development and is implicated in the regulation of trophoblast differentiation. Prolonged hypoxic conditions in the placenta are related to the development of preeclampsia. MicroRNAs (miRNAs) are noncoding, single-stranded RNAs that modulate gene expression by targeting messenger RNA. We hypothesized that, under hypoxic conditions, trophoblasts may have a unique miRNA profile that may play a critical role in placental development. METHODS: Total RNA was extracted from human trophoblast, HChEpC1b, exposed to normoxia (20% O2) or hypoxia (2% O2) for 24 h, and the miRNA expression profiles were investigated using a microRNA array. Several differential miRNAs were selected and validated using real-time reverse transcription PCR. We identified potential targets of these miRNAs using in silico analysis. We confirmed a potential target protein by western blot analysis and luciferase assays. RESULTS: The expression of miR-365 was significantly upregulated under hypoxic conditions. In silico analysis showed that miR-365 targeted human leukocyte antigen (HLA)-G. Both hypoxic conditions and overexpression of miR-365 inhibited the expression of HLA-G proteins. The overexpression of miR-365 also decreased the activity of the luciferase reporter containing the 3'-untranslated region (UTR) of HLA-G with the predicted miR-365-binding site. DISCUSSION: HLA-G is a non-classical HLA class-Ib molecule that is expressed mainly in extravillous trophoblasts and which plays a key role in maintaining immune tolerance at the maternal-fetal interface. Our results indicate that miR-365 targets the HLA-G 3' UTR to repress its expression. The expression of miR-365 may play an important role in human placental development and in immunoprotection of the semiallogenic embryo.
INTRODUCTION:Hypoxia occurs in the first trimester of placental development and is implicated in the regulation of trophoblast differentiation. Prolonged hypoxic conditions in the placenta are related to the development of preeclampsia. MicroRNAs (miRNAs) are noncoding, single-stranded RNAs that modulate gene expression by targeting messenger RNA. We hypothesized that, under hypoxic conditions, trophoblasts may have a unique miRNA profile that may play a critical role in placental development. METHODS: Total RNA was extracted from human trophoblast, HChEpC1b, exposed to normoxia (20% O2) or hypoxia (2% O2) for 24 h, and the miRNA expression profiles were investigated using a microRNA array. Several differential miRNAs were selected and validated using real-time reverse transcription PCR. We identified potential targets of these miRNAs using in silico analysis. We confirmed a potential target protein by western blot analysis and luciferase assays. RESULTS: The expression of miR-365 was significantly upregulated under hypoxic conditions. In silico analysis showed that miR-365 targeted humanleukocyte antigen (HLA)-G. Both hypoxic conditions and overexpression of miR-365 inhibited the expression of HLA-G proteins. The overexpression of miR-365 also decreased the activity of the luciferase reporter containing the 3'-untranslated region (UTR) of HLA-G with the predicted miR-365-binding site. DISCUSSION: HLA-G is a non-classical HLA class-Ib molecule that is expressed mainly in extravillous trophoblasts and which plays a key role in maintaining immune tolerance at the maternal-fetal interface. Our results indicate that miR-365 targets the HLA-G 3' UTR to repress its expression. The expression of miR-365 may play an important role in human placental development and in immunoprotection of the semiallogenic embryo.
Authors: Charles A Ducsay; Ravi Goyal; William J Pearce; Sean Wilson; Xiang-Qun Hu; Lubo Zhang Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312
Authors: Esperance Schaefer; Winona Wu; Christina Mark; Andrew Yang; Erik DiGiacomo; Charles Carlton-Smith; Shadi Salloum; Cynthia Brisac; Wenyu Lin; Kathleen E Corey; Raymond T Chung Journal: Hepatol Commun Date: 2017-05-18
Authors: Moniek H C Craenmehr; Iris Nederlof; Milo Cao; Jos J M Drabbels; Marijke J Spruyt-Gerritse; Jacqueline D H Anholts; Hanneke M Kapsenberg; Janine A Stegehuis; Carin van der Keur; Esther Fasse; Geert W Haasnoot; Marie-Louise P van der Hoorn; Frans H J Claas; Sebastiaan Heidt; Michael Eikmans Journal: Int J Mol Sci Date: 2019-02-01 Impact factor: 5.923
Authors: Jennifer R King; Melissa L Wilson; Szabolcs Hetey; Peter Kiraly; Koji Matsuo; Antonio V Castaneda; Eszter Toth; Tibor Krenacs; Petronella Hupuczi; Paulette Mhawech-Fauceglia; Andrea Balogh; Andras Szilagyi; Janos Matko; Zoltan Papp; Lynda D Roman; Victoria K Cortessis; Nandor Gabor Than Journal: Int J Mol Sci Date: 2019-10-10 Impact factor: 5.923
Authors: Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten Journal: Front Immunol Date: 2021-07-06 Impact factor: 7.561